2024-2030 Global Gastrointestinal Stromal Tumor Drug Industry Research & Trends Analysis Report

2024-2030 Global Gastrointestinal Stromal Tumor Drug Industry Research & Trends Analysis Report

  • Publication Date: 2024-07-27
  • Report Id: 1724718
  • Industry: Pharma & Healthcare
  • Report Page: 153
  • Chart: 152
sample
customized
pdf

PDF Download

  • Publication Date: 2024-07-27
  • Report Id: 1724718
  • Industry: Pharma & Healthcare
  • Report Page: 153
  • Chart: 152
sample
customized
pdf

PDF Download

  • Table of Contents
  • Description
  • Table of Figures
  • Need a Quote? quote

1 Market Overview
1.1 Gastrointestinal Stromal Tumor Drug Definition
1.2 Global Gastrointestinal Stromal Tumor Drug Market Size and Forecast
1.2.1 By Revenue, Global Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
1.2.2 By Sales Volume, Global Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
1.2.3 Global Gastrointestinal Stromal Tumor Drug Price Trend, 2019-2030
1.3 China Gastrointestinal Stromal Tumor Drug Market Size and Forecast
1.3.1 By Revenue, China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
1.3.2 By Sales Volume, China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
1.3.3 China Gastrointestinal Stromal Tumor Drug Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Gastrointestinal Stromal Tumor Drug Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Gastrointestinal Stromal Tumor Drug Share in Global Market, 2019-2030
1.4.3 Gastrointestinal Stromal Tumor Drug Market Size: China VS Global, 2019-2030
1.5 Gastrointestinal Stromal Tumor Drug Market Dynamics
1.5.1 Gastrointestinal Stromal Tumor Drug Market Drivers
1.5.2 Gastrointestinal Stromal Tumor Drug Market Restraints
1.5.3 Gastrointestinal Stromal Tumor Drug Industry Trends
1.5.4 Gastrointestinal Stromal Tumor Drug Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Company, 2019-2024
2.2 Global Gastrointestinal Stromal Tumor Drug Sales Volume by Company, 2019-2024
2.3 Global Gastrointestinal Stromal Tumor Drug Price by Company, 2019-2024
2.4 Global Gastrointestinal Stromal Tumor Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Gastrointestinal Stromal Tumor Drug Concentration Ratio
2.6 Global Gastrointestinal Stromal Tumor Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Gastrointestinal Stromal Tumor Drug Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Gastrointestinal Stromal Tumor Drug Revenue by Company, 2019-2024
3.2 China Gastrointestinal Stromal Tumor Drug Sales Volume by Company, 2019-2024
3.3 China Gastrointestinal Stromal Tumor Drug Gastrointestinal Stromal Tumor Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Gastrointestinal Stromal Tumor Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Gastrointestinal Stromal Tumor Drug Domestic VS Export
3.6 China Market, Gastrointestinal Stromal Tumor Drug Import & Export
3.6.1 China Market, Gastrointestinal Stromal Tumor Drug Import & Export, 2019-2030
3.6.2 China Gastrointestinal Stromal Tumor Drug Import & Export Trends
3.6.3 Main Sources of China Gastrointestinal Stromal Tumor Drug Import
3.6.4 Export Destination of China Gastrointestinal Stromal Tumor Drug

4 Gastrointestinal Stromal Tumor Drug Production by Region
4.1 Global Gastrointestinal Stromal Tumor Drug Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Gastrointestinal Stromal Tumor Drug Manufacturers
4.3 Global Major Manufacturers, Gastrointestinal Stromal Tumor Drug Capacity Expansion and Future Plans
4.4 Global Gastrointestinal Stromal Tumor Drug Capacity by Region
4.5 Global Gastrointestinal Stromal Tumor Drug Production by Region
4.5.1 Global Gastrointestinal Stromal Tumor Drug Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Gastrointestinal Stromal Tumor Drug Production by Region, 2019-2024
4.5.3 Global Gastrointestinal Stromal Tumor Drug Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis
5.1 Gastrointestinal Stromal Tumor Drug Industry Chain
5.2 Gastrointestinal Stromal Tumor Drug Upstream Analysis
5.2.1 Gastrointestinal Stromal Tumor Drug Core Raw Materials
5.2.2 Main Manufacturers of Gastrointestinal Stromal Tumor Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Gastrointestinal Stromal Tumor Drug Production Mode
5.6 Gastrointestinal Stromal Tumor Drug Procurement Model
5.7 Gastrointestinal Stromal Tumor Drug Industry Sales Model and Sales Channels
5.7.1 Gastrointestinal Stromal Tumor Drug Sales Model
5.7.2 Gastrointestinal Stromal Tumor Drug Typical Distributors

6 Sights by Product Type
6.1 Gastrointestinal Stromal Tumor Drug Classification
6.1.1 Imatinib
6.1.2 Sunitinib
6.1.3 Regorafenib
6.1.4 Ripretinib
6.1.5 Others
6.2 by Type, Global Gastrointestinal Stromal Tumor Drug Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 by Type, Global Gastrointestinal Stromal Tumor Drug Revenue, 2019-2030
6.4 by Type, Global Gastrointestinal Stromal Tumor Drug Sales Volume, 2019-2030
6.5 by Type, Global Gastrointestinal Stromal Tumor Drug Price, 2019-2030

7 Sights by Application
7.1 Gastrointestinal Stromal Tumor Drug Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 by Application, Global Gastrointestinal Stromal Tumor Drug Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 by Application, Global Gastrointestinal Stromal Tumor Drug Revenue, 2019-2030
7.4 by Application, Global Gastrointestinal Stromal Tumor Drug Sales Volume, 2019-2030
7.5 by Application, Global Gastrointestinal Stromal Tumor Drug Price, 2019-2030

8 Sales Sights by Region
8.1 By Region, Global Gastrointestinal Stromal Tumor Drug Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Gastrointestinal Stromal Tumor Drug Revenue, 2019-2030
8.3 By Region, Global Gastrointestinal Stromal Tumor Drug Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Gastrointestinal Stromal Tumor Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Gastrointestinal Stromal Tumor Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Market Share
8.7 South America
8.7.1 South AmericaGastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Gastrointestinal Stromal Tumor Drug Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Gastrointestinal Stromal Tumor Drug Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Gastrointestinal Stromal Tumor Drug Revenue, 2019-2030
9.3 By Country, Global Gastrointestinal Stromal Tumor Drug Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S.Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.4.2 By Company, U.S. Gastrointestinal Stromal Tumor Drug Sales Volume Market Share, 2023
9.4.3 by Type, U.S. Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.4.4 by Application, U.S. Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.5.2 By Company, Europe Gastrointestinal Stromal Tumor Drug Sales Volume Market Share, 2023
9.5.3 by Type, Europe Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.5.4 by Application, Europe Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.6.2 By Company, China Gastrointestinal Stromal Tumor Drug Sales Volume Market Share, 2023
9.6.3 by Type, China Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.6.4 by Application, China Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.7.2 By Company, Japan Gastrointestinal Stromal Tumor Drug Market Share, 2023
9.7.3 by Type, Japan Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.7.4 by Application, Japan Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.8.2 By Company, South Korea Gastrointestinal Stromal Tumor Drug Market Share, 2023
9.8.3 by Type, South Korea Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.8.4 by Application, South Korea Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Gastrointestinal Stromal Tumor Drug Market Share, 2023
9.9.3 by Type, Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.9.4 by Application, Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.10.2 By Company, India Gastrointestinal Stromal Tumor Drug Market Share, 2023
9.10.3 by Type, India Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.10.4 by Application, India Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
9.11.2 By Company, Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Share, 2023
9.11.3 by Type, Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030
9.11.4 by Application, Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Size, Share, 2023 VS 2030

10 Manufacturers Profile
10.1 Novartis
10.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.1.3 Novartis Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Novartis Company Profile and Main Business
10.1.5 Novartis Recent Developments
10.2 Bayer Pharmaceuticals
10.2.1 Bayer Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Bayer Pharmaceuticals Company Profile and Main Business
10.2.5 Bayer Pharmaceuticals Recent Developments
10.3 Glenmark Pharmaceuticals Ltd.
10.3.1 Glenmark Pharmaceuticals Ltd. Company Information, Head Office, Market Area, and Industry Position
10.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Glenmark Pharmaceuticals Ltd. Company Profile and Main Business
10.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments
10.4 Sun Pharmaceuticals
10.4.1 Sun Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Sun Pharmaceuticals Company Profile and Main Business
10.4.5 Sun Pharmaceuticals Recent Developments
10.5 Actavis Generics
10.5.1 Actavis Generics Company Information, Head Office, Market Area, and Industry Position
10.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Actavis Generics Company Profile and Main Business
10.5.5 Actavis Generics Recent Developments
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
10.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Dr. Reddy's Laboratories Company Profile and Main Business
10.6.5 Dr. Reddy's Laboratories Recent Developments
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
10.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.8 Apotex Inc.
10.8.1 Apotex Inc. Company Information, Head Office, Market Area, and Industry Position
10.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Apotex Inc. Company Profile and Main Business
10.8.5 Apotex Inc. Recent Developments
10.9 Mylan Pharms Inc.
10.9.1 Mylan Pharms Inc. Company Information, Head Office, Market Area, and Industry Position
10.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Mylan Pharms Inc. Company Profile and Main Business
10.9.5 Mylan Pharms Inc. Recent Developments
10.10 Bulat Pharmaceutical
10.10.1 Bulat Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Bulat Pharmaceutical Company Profile and Main Business
10.10.5 Bulat Pharmaceutical Recent Developments
10.11 MSN Laboratories
10.11.1 MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
10.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 MSN Laboratories Company Profile and Main Business
10.11.5 MSN Laboratories Recent Developments
10.12 Vannsh Life Sciences
10.12.1 Vannsh Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Vannsh Life Sciences Company Profile and Main Business
10.12.5 Vannsh Life Sciences Recent Developments
10.13 Beacon Pharmaceuticals
10.13.1 Beacon Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Beacon Pharmaceuticals Company Profile and Main Business
10.13.5 Beacon Pharmaceuticals Recent Developments
10.14 Drug International
10.14.1 Drug International Company Information, Head Office, Market Area, and Industry Position
10.14.2 Drug International Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Drug International Company Profile and Main Business
10.14.5 Drug International Recent Developments
10.15 Deciphera Pharmaceuticals
10.15.1 Deciphera Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Deciphera Pharmaceuticals Company Profile and Main Business
10.15.5 Deciphera Pharmaceuticals Recent Developments
10.16 CSPC Pharmaceuticals
10.16.1 CSPC Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.16.4 CSPC Pharmaceuticals Company Profile and Main Business
10.16.5 CSPC Pharmaceuticals Recent Developments
10.17 Hansoh Pharmaceuticals
10.17.1 Hansoh Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Hansoh Pharmaceuticals Company Profile and Main Business
10.17.5 Hansoh Pharmaceuticals Recent Developments
10.18 Kelun Pharmaceuticals
10.18.1 Kelun Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Kelun Pharmaceuticals Company Profile and Main Business
10.18.5 Kelun Pharmaceuticals Recent Developments
10.19 Zai Lab
10.19.1 Zai Lab Company Information, Head Office, Market Area, and Industry Position
10.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.19.4 Zai Lab Company Profile and Main Business
10.19.5 Zai Lab Recent Developments
10.20 CStone Pharmaceuticals
10.20.1 CStone Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.20.4 CStone Pharmaceuticals Company Profile and Main Business
10.20.5 CStone Pharmaceuticals Recent Developments
10.21 China Biopharmaceuticals
10.21.1 China Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
10.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.21.4 China Biopharmaceuticals Company Profile and Main Business
10.21.5 China Biopharmaceuticals Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

电话
CONTACT US!

We will contact you back in 24 hours.

Email: info@yhresearch.com

Send Now
Send Now